NEW YORK (GenomeWeb News) – GE Healthcare Life Sciences and NetBio said on Monday they will commercialize new products for DNA sample collection and analysis for the forensics market.

NEW YORK (GenomeWeb News) – BGI and the University of Birmingham in the UK today announced a collaboration directed at research on environmental and human health.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration is seeking a small business to help support management of two of its genomic data resources run by the National Center for Toxicological Research.

NEW YORK (GenomeWeb News) – GenMark Diagnostics and Advanced Liquid Logic today said they have executed definitive agreements to co-develop an all-digital, fully integrated in vitro diagnostic platform combining ALL's electrowetting technology and GenMark's electrochemical detection.

In the fight to gain market share in the competitive desktop sequencing market, at least one vendor is pursuing customers by incentivizing them to retire competitors' instruments.

This article was originally published July 26. Illumina is getting ready to ship upgrades for its MiSeq and HiSeq sequencers and saw strong growth in sequencing consumables sales in the second quarter.

This article was originally published July 27.

In a presentation outlining Roche's 2012 financial results for the first half of the year, the company shed further light on its previously disclosed plans to restructure its Applied Science business, noting that it intends to focus on sequencing, qPCR, and custom biotech service

Researchers in the genomics community expect to sequence more than 48,600 whole human genomes in 2013, a 40 percent increase over 2012, according to results from a survey conducted by GenomeWeb in collaboration with investment firm Mizuho Securities.

Novel microRNAs differentially expressed during aging in the mouse brain. Inukai S, de Lencastre A, Turner M, Slack F. PLoS One. 2012;7(7):e40028.

Complete Genomics is now including six months of access to Ingenuity's Variant Analysis software as part of its whole-genome sequencing services. The software will help customers analyze and interpret biologically relevant genetic variations.

A more precise testing methodology for cancer presents its own set of problems, says one blogger.

Elsevier launches an applied genomics journal.

In the British Journal of Cancer this week: PIM kinases in diffuse large B-cell lymphoma, functional validation of a multi-tumor-type proliferation signature, and more.

The Edinburgh Evening News profiles Mark Blaxter.

NEW YORK (GenomeWeb News) – Bruker today reported that revenues for its second quarter increased 5 percent year over year as the company missed the consensus Wall Street estimate on the top and bottom line.

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market Monday that its second-quarter revenues inched up 1 percent as a decline in systems and consumables sales was offset by a sharp rise in assay revenue.

NEW YORK (GenomeWeb News) – Roche today said that it will transfer its Cellavista Systems business to SynenTec, a German firm that is the original inventor of the technology.

In PNAS this week: human artificial chromosome assembly assays shed light on de novo centromere assembly, and more.

NEW YORK (GenomeWeb News) – Sigma-Aldrich today said that it has signed an agreement to market Axiogenesis' mouse-induced pluripotent stem cell-derived cardiomyocytes and smooth muscle cells for preclinical cardiotoxicity screening.

Patenting the products of research doesn't prevent future research, says one patent lawyer.

In research, says one blogger, it pays to double-check.

NEW YORK (GenomeWeb News) – As it awaits completion of its $3.7 billion buy of Gen-Probe, Hologic reported after the close of the market on Monday that its diagnostics business segment grew 11 percent year over yea

NEW YORK (GenomeWeb News) – MolecularMD has submitted a Premarket Approval application with the US Food and Drug Administration for a companion diagnostic test to leukemia drug ponatinib.

One company is looking to improve cancer treatments by tailoring them to patients.